Increase in the peripheral lymphocyte populations expressing CD54 (ICAM- 1) after hyperthermic isolated limb perfusion in patients with malignant melanoma: An analysis of four cases

Journal of Dermatological Science

Volumn 17, Issue 1, 1998, Pages 33-38

  Nakayama, Juichiro ^a   Guan, Xiao Chun ^a   Tominaga, Ryuji ^a   Nagae, Shonosuke ^a   Matsuda, Kazuhisa ^a   Nakao, Tomoko ^a   Rikihisa, Wataru ^a   Yang, Hsien Hsun ^a   Shibata, Satoko ^a   Eguchi, Akira ^a   Takeuchi, Satoshi ^a   Hori, Yoshiaki ^a   Yasui, Hisataka ^a   Takahashi, Seisuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CD54; Hypertherrnic isolated limb perfusion; ICAM 1; Malignant melanoma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IMMUNOMODULATION; IMMUNOSTIMULATION; LIMB PERFUSION; MALE; MELANOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, NATURAL; LYMPHOCYTES; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 17544402274     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(97)00073-X     Document Type: Article

References (8)

1. Skene AI, Bulman AS, Williams TR, Thomas JM, Westber G Hyperthermic isolated limb perfusions for malignant melanoma. Br J Surg. 77:1990;765-767.
2. Kettelhack C, Kraus T, Hupp T, Manner M, Schlag P Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol. 16:1990;370-375.
3. Nakayama J, Takeuchi M, Mayumi H, Nagae S, Matsuda K, Yasui H, Takahashi S, Hori Y Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or β-interferon. J Dermatol. 23:1996;6-15.
4. Nakayama J, Nakao T, Mashino T, Nagae S, Hori Y, Mayumi H, Tominaga R, Yasui H, Matsuda K, Takahashi S. Kinetics of immunological parameters in patients with malignant melanoma treated with hyperthermic isolated limb perfusion. J Dermatol Sci. 15:1997;1-8.
5. Anichini A, Mortarini R, Supino R, Parmiani G Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA-profile and invasive ability. Int J Cancer. 46:1990;508-515.
6. Eguchi H, Horikoshi T, Takahashi M, Imai K, Tsujisaki M, Kageshita T. The effect of INF-β on the expression of ICAM-1 (Intercellular Adhesion Molecule-1) on melanoma cells in vitro and in vivo. Jpn J Dermatol 1992;102:807-14 (in Japanese).
7. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor-necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 147:1991;4398-4401.
8. Nakayama J, Kageshita T, Nakashima M, Tsujisaki M, Imai K, Hori Y Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro. Pigment Cell Res. 9:1996;154-158.